Raju K, Taneja I, Valicherla G, Challagundla M, Rashid M, Syed A, et al. No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats. Sci Rep. 2015;5:16126 pubmed publisher

Yan T, Lu L, Xie C, Chen J, Peng X, Zhu L, et al. Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients. Mol Cancer Ther. 2015;14:2874-86 pubmed publisher

Briolotti P, Chaloin L, Balaguer P, Da Silva F, Tománková V, Pascussi J, et al. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling. Toxicol Sci. 2015;148:261-75 pubmed publisher

Uehara S, Uno Y, Inoue T, Kawano M, Shimizu M, Toda A, et al. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole. Drug Metab Dispos. 2015;43:1408-16 pubmed publisher

He W, Wu J, Ning J, Hou J, Xin H, He Y, et al. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice. Toxicol In Vitro. 2015;29:1569-76 pubmed publisher

Yang A, He X, Chen J, He L, Jin C, Wang L, et al. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2. Chem Biol Interact. 2015;237:133-40 pubmed publisher

Holm N, Nielsen L, Linnet K. CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48. AAPS J. 2015;17:1237-45 pubmed publisher

Abe Y, Ota E, Harada H, Kanbe H, Kojima Y, Kanazawa T, et al. Species differences in the metabolism of ritobegron in vitro and assessment of potential interactions with transporters and cytochrome P450 enzymes. Pharmazie. 2015;70:38-46 pubmed

Wang Y, Jiang Y, Fan X, Tan H, Zeng H, Wang Y, et al. Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicol Lett. 2015;236:82-9 pubmed publisher

Jin C, He X, Zhang F, He L, Chen J, Wang L, et al. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4. Xenobiotica. 2015;45:571-7 pubmed publisher

Jiang Y, Fan X, Wang Y, Tan H, Chen P, Zeng H, et al. Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chem Biol Interact. 2015;231:83-9 pubmed publisher

Uehara S, Uno Y, Inoue T, Murayama N, Shimizu M, Sasaki E, et al. Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus). Drug Metab Dispos. 2015;43:735-42 pubmed publisher

Zhang W, Li R, Qiu J, Zhang Z, Wang H, Bian L, et al. Determination of kurarinone in rat plasma by UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;986-987:31-4 pubmed publisher

Zhou X, Cheung C, Yang J, Or P, Lee W, Yeung J. Danshen (Salvia miltiorrhiza) water extract inhibits paracetamol-induced toxicity in primary rat hepatocytes via reducing CYP2E1 activity and oxidative stress. J Pharm Pharmacol. 2015;67:980-9 pubmed publisher

Lee J, Lee S, Lee K, Oh S, Kim S. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method. Chem Biol Interact. 2015;229:109-18 pubmed publisher

Jeon J, Oh S, Lee J, Ryu C, Kim Y, Lee B, et al. Metabolic characterization of meso-dihydroguaiaretic acid in liver microsomes and in mice. Food Chem Toxicol. 2015;76:94-102 pubmed publisher

Guo W, Shi X, Wang W, Zhang W, Li J. Identification of the rat liver cytochrome P450 enzymes involved in the metabolism of the calcium channel blocker dipfluzine hydrochloride. Environ Toxicol Pharmacol. 2014;38:901-12 pubmed publisher

Spaggiari D, Mehl F, Desfontaine V, Grand Guillaume Perrenoud A, Fekete S, Rudaz S, et al. Comparison of liquid chromatography and supercritical fluid chromatography coupled to compact single quadrupole mass spectrometer for targeted in vitro metabolism assay. J Chromatogr A. 2014;1371:244-56 pubmed publisher

Huang X, Guo Y, Huang W, Zhang W, Tan Z, Peng J, et al. Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San. PLoS ONE. 2014;9:e113819 pubmed publisher

Chang Z, Li J, Zhai Q. Evaluation on activity of cytochrome p450 enzymes in turbot via a probe drug cocktail. J Aquat Anim Health. 2014;26:272-7 pubmed publisher

Shimokawa Y, Sasahara K, Yoda N, Mizuno K, Umehara K. Delamanid does not inhibit or induce cytochrome p450 enzymes in vitro. Biol Pharm Bull. 2014;37:1727-35 pubmed

Jiang Y, Fan X, Wang Y, Chen P, Zeng H, Tan H, et al. Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration. Toxicol Sci. 2015;143:107-15 pubmed publisher

Gerbal Chaloin S, Dumé A, Briolotti P, Klieber S, Raulet E, Duret C, et al. The WNT/β-catenin pathway is a transcriptional regulator of CYP2E1, CYP1A2, and aryl hydrocarbon receptor gene expression in primary human hepatocytes. Mol Pharmacol. 2014;86:624-34 pubmed publisher

Fan X, Jiang Y, Wang Y, Tan H, Zeng H, Wang Y, et al. Wuzhi tablet (Schisandra Sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways. Drug Metab Dispos. 2014;42:1982-90 pubmed publisher

Wang Z, Yang H, Sun W, Huang C, Cui X, Qiu X, et al. UPLC-MS/MS determination of thiamphenicol in human plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;967:235-9 pubmed publisher

Dinger J, Meyer M, Maurer H. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 2014;230:28-35 pubmed publisher

Wang B, Yang S, Hu J, Li Y. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. J Ethnopharmacol. 2014;155:1473-82 pubmed publisher

Nirogi R, Palacharla R, Uthukam V, Manoharan A, Srikakolapu S, Kalaikadhiban I, et al. Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays. Xenobiotica. 2015;45:95-106 pubmed publisher

Kwak H, Kim H, Oh S, Kim S. Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL/6 mice. Arch Pharm Res. 2015;38:857-64 pubmed publisher

Masek V, Starha P, Harvanova M, Michalova M, Milde D, Trávníček Z, et al. Interaction of selected platinum(II) complexes containing roscovitine-based CDK inhibitors as ligands with human liver microsomal cytochrome P450. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:382-7 pubmed publisher

Subramanian M, Kurawattimath V, Pocha K, Freeden C, Rao I, Mariappan T, et al. Role of hepatic blood flow and metabolism in the pharmacokinetics of ten drugs in lean, aged and obese rats. Xenobiotica. 2014;44:1108-16 pubmed publisher

Lee S, Jang H, Lee J, Kwon K, Oh S, Kim S. Inhibition of cytochrome P450 by ethambutol in human liver microsomes. Toxicol Lett. 2014;229:33-40 pubmed publisher

Spaggiari D, Geiser L, Daali Y, Rudaz S. Phenotyping of CYP450 in human liver microsomes using the cocktail approach. Anal Bioanal Chem. 2014;406:4875-87 pubmed publisher

Bae S, Kwon M, Park J, Kim D, Kim D, Kang J, et al. Metabolic drug-drug interaction potential of macrolactin A and 7-O-succinyl macrolactin A assessed by evaluating cytochrome P450 inhibition and induction and UDP-glucuronosyltransferase inhibition in vitro. Antimicrob Agents Chemother. 2014;58:5036-46 pubmed publisher

Dinger J, Meyer M, Maurer H. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail. Anal Bioanal Chem. 2014;406:4453-64 pubmed publisher

Huang Y, Zheng S, Xu Z, Hou Y. Effects of Alismatis rhizome on rat cytochrome P450 enzymes. Pharm Biol. 2014;52:681-7 pubmed publisher

Yao H, Hsu Y, Lii C, Lin A, Chang K, Yang H. Effect of commercially available green and black tea beverages on drug-metabolizing enzymes and oxidative stress in Wistar rats. Food Chem Toxicol. 2014;70:120-7 pubmed publisher

Di Rago M, Saar E, Rodda L, Turfus S, Kotsos A, Gerostamoulos D, et al. Fast targeted analysis of 132 acidic and neutral drugs and poisons in whole blood using LC-MS/MS. Forensic Sci Int. 2014;243:35-43 pubmed publisher

Srikanth C, Joshi P, Bikkasani A, Porwal K, Gayen J. Bone distribution study of anti leprotic drug clofazimine in rat bone marrow cells by a sensitive reverse phase liquid chromatography method. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;960:82-6 pubmed publisher

Liang D, Zheng S. Effects of icaritin on cytochrome P450 enzymes in rats. Pharmazie. 2014;69:301-5 pubmed

Zheng Y, Bae S, Choi E, Park J, Kim S, Jang M, et al. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition. Food Chem Toxicol. 2014;68:117-27 pubmed publisher

Srinivas N. Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives. Eur J Drug Metab Pharmacokinet. 2015;40:1-12 pubmed publisher

Choi M, Kwon M, Cho Y, Choi H, Kim Y, Kang H. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats. Biopharm Drug Dispos. 2014;35:264-74 pubmed publisher

Langhammer A, Nilsen O. Fennel and raspberry leaf as possible inhibitors of acetaminophen oxidation. Phytother Res. 2014;28:1573-6 pubmed publisher

Feil K, Claaßen J, Bardins S, Teufel J, Krafczyk S, Schneider E, et al. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial. Neurology. 2013;81:1152-8 pubmed publisher

Lin W, Zhang J, Ling X, Yu N, Li J, Yang H, et al. Evaluation of the effect of TM208 on the activity of five cytochrome P450 enzymes using on-line solid-phase extraction HPLC-DAD: a cocktail approach. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;923-924:29-36 pubmed publisher

Zhai X, Lu Y. Development and validation of a simple LC method for the determination of phenacetin, coumarin, tolbutamide, chlorzoxazone, testosterone and their metabolites as markers of cytochromes 1A2, 2A6, 2C11, 2E1 and 3A2 in rat microsomal medium. Pharmazie. 2013;68:19-26 pubmed

Paloncýová M, Berka K, Otyepka M. Molecular insight into affinities of drugs and their metabolites to lipid bilayers. J Phys Chem B. 2013;117:2403-10 pubmed publisher

Gao N, Zou D, Qiao H. Concentration-dependent inhibitory effect of Baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in vitro and in vivo. PLoS ONE. 2013;8:e53038 pubmed publisher

Gao J, Shi Z, Zhu S, Li G, Yan R, Yao M. Influences of processed rhubarbs on the activities of four CYP isozymes and the metabolism of saxagliptin in rats based on probe cocktail and pharmacokinetics approaches. J Ethnopharmacol. 2013;145:566-72 pubmed publisher

Peng H, Auchus R. The action of cytochrome b(5) on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65. Biochemistry. 2013;52:210-20 pubmed publisher

Gao Z, Todorov B, Barrett C, van Dorp S, Ferrari M, van den Maagdenberg A, et al. Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice. J Neurosci. 2012;32:15533-46 pubmed publisher

Laube M, Kimpel S, Dietl P, Thome U, Wittekindt O. Benzimidazolones enhance the function of epithelial Na? transport. Br J Pharmacol. 2013;168:1329-40 pubmed publisher

Yamasaki I, Yamada M, Uotsu N, Teramoto S, Takayanagi R, Yamada Y. Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats. Biomed Res. 2012;33:235-42 pubmed

Abdelaleem E, Abdelwahab N. Stability-indicating TLC-densitometric method for simultaneous determination of paracetamol and chlorzoxazone and their toxic impurities. J Chromatogr Sci. 2013;51:187-91 pubmed publisher

Desai P, Patel N, Sherikar O, Mehta P. Development and validation of packed column supercritical fluid chromatographic technique for quantification of chlorzoxazone, paracetamol and aceclofenac in their individual and combined dosage forms. J Chromatogr Sci. 2012;50:769-74 pubmed publisher

Li J, Wei D, Wang J, Yu Z, Chou K. Molecular dynamics simulations of CYP2E1. Med Chem. 2012;8:208-21 pubmed

Li Z, Zhang W, Lu X, Li J, He B, Jiang H, et al. Reaction temperature alters chorzoxazone metabolism in carp (Cyprinus carpio) hepatic microsomes. Fish Physiol Biochem. 2012;38:1225-31 pubmed publisher

Ghobadi C, Johnson T, Aarabi M, Almond L, Allabi A, Rowland Yeo K, et al. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. Clin Pharmacokinet. 2011;50:809-22 pubmed publisher

Han Y, Li D, Ren B, Jing G, Meng X, Zhou Z, et al. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. J Ethnopharmacol. 2012;139:104-9 pubmed publisher

Attia M, Ramsis M, Khalil L, Hashem S. Spectrofluorimetric assessment of chlorzoxazone and ibuprofen in pharmaceutical formulations by using Eu-tetracycline HCl optical sensor doped in sol-gel matrix. J Fluoresc. 2012;22:779-88 pubmed publisher

Shaik I, Mehvar R. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats. J Pharm Sci. 2011;100:5281-92 pubmed publisher

Jones J, Joswig Jones C, Hebner M, Chu Y, Koop D. The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1. Chem Biol Interact. 2011;193:50-6 pubmed publisher

Nakanishi Y, Matsushita A, Matsuno K, Iwasaki K, Utoh M, Nakamura C, et al. Regional distribution of drug-metabolizing enzyme activities in the liver and small intestine of cynomolgus monkeys. Drug Metab Pharmacokinet. 2011;26:288-94 pubmed publisher

Wu J, Yue J, Feng Y. Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:260-6 pubmed publisher

Hopf F, Simms J, Chang S, Seif T, Bartlett S, Bonci A. Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biol Psychiatry. 2011;69:618-24 pubmed publisher

Van Eerdenbrugh B, Taylor L. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Mol Pharm. 2010;7:1328-37 pubmed publisher

Alviña K, Khodakhah K. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci. 2010;30:7258-68 pubmed publisher

Alviña K, Khodakhah K. KCa channels as therapeutic targets in episodic ataxia type-2. J Neurosci. 2010;30:7249-57 pubmed publisher

Hukkanen J, Jacob Iii P, Peng M, Dempsey D, Benowitz N. Effects of nicotine on cytochrome P450 2A6 and 2E1 activities. Br J Clin Pharmacol. 2010;69:152-9 pubmed publisher

Mizuno D, Tanaka E, Tanno K, Misawa S. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats. Arch Toxicol. 2000;74:139-44 pubmed

Syme C, Gerlach A, Singh A, Devor D. Pharmacological activation of cloned intermediate- and small-conductance Ca(2+)-activated K(+) channels. Am J Physiol Cell Physiol. 2000;278:C570-81 pubmed

Singh A, Devor D, Gerlach A, Gondor M, Pilewski J, Bridges R. Stimulation of Cl(-) secretion by chlorzoxazone. J Pharmacol Exp Ther. 2000;292:778-87 pubmed

Powers B, Cattau E, Zimmerman H. Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases. Arch Intern Med. 1986;146:1183-6 pubmed